Breakthrough spatial biology applications such as spatial phenotyping (whole-slide imaging at a single-cell/sub-cellular resolution with tissue context) span the discovery-to-clinical continuum. To minimize time and maximize value along the continuum, it is imperative to make discoveries happen faster and at scale.

 

Immunotherapies have led to durable benefit in a number of solid malignancies including lung, head and neck, and skin cancers. Identifying patients likely to achieve benefit remains an unmet clinical need. The tumor microenvironment (TME) is now recognized as a driving factor dictating response to immunotherapies.

 

This webcast will present comprehensive, cell-by-cell, spatial phenotyping of a head and neck tumor to delineate tissue signatures associated with response to therapy.